title: [The role of testosterone undecanoate in correcting disorders of the copulative function].
abstract: Testosterone andecanoate (andriol) was used for treatment of copulative dysfunction in 18 young and middle-aged males in a dose 160 mg/day (a 10-12-day treatment course) or 40-80 mg/day (up to 6 week maintenance course). Clinical responses concerning such sexual symptoms as libido, erection, ejaculation and orgasm were achieved in most of the patients. Pretreatment blood levels of testosterone were not decreased. The treatment aroused these levels which persisted higher that pretreatment ones for 3 months. Estradiol was slightly higher after the treatment. Andriol is recommended for treatment of copulative dysfunction in young and middle-aged males.
authors.forename: O L
authors.initials: OL
authors.lastname: Tiktinskiĭ
authors.forename: S N
authors.initials: SN
authors.lastname: Kalinina
authors.forename: K Iu
authors.initials: KIu
authors.lastname: Zubovskiĭ
mesh_terms: D000328:Adult; D004341:Drug Evaluation; D006801:Humans; D008297:Male; D008875:Middle Aged; D012735:Sexual Dysfunction, Physiological / Q000188:drug therapy*; D013001:Somatoform Disorders / Q000188:drug therapy*; D013739:Testosterone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D045165:Testosterone Congeners / Q000627:therapeutic use*; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D045165:Testosterone Congeners; D013739:Testosterone; C010792:testosterone undecanoate
vernacular_title: Rol' testosterona andekanoata v korrektsii narusheniĭ kopuliativnoĭ funktsii.